We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter into Agreement for Testim®

News   May 22, 2012

 
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter into Agreement for Testim®
 
 
 

RELATED ARTICLES

Miniature Chip Quantifies Cell Survival Much Faster than Gold Standard

News

A new toxicity test can measure chemical effects on cell survival with much greater sensitivity than some of the most popular tests used today.

READ MORE

Abcam Expands Custom Services Capabilities with the Acquisition of Calico Biolabs

News

Company's strategic expansion will further support their vision to supply the best antibodies for today's and tomorrow's targets of interest.

READ MORE

Stem Cell Transplant for Vision Impairment Condition: Safe and Feasible

News

Doctors made the world-first step by carrying out a clinical trial using stem cells from donors to create tissue that was transplanted into patients with a condition that causes blindness.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE